Australia - inglese - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 32832 - uncoated knee tibia prosthesis, metallic - the rbk revision tibia cemented is a component of the rbk knee system. it is made of cobalt-chrome-molybdenum alloy and acts as a baseplate for the insert component that provides the articulating surface of the replacement knee system. the underside features a coned taper for attachment of the tibial stem component and four threaded holes for attaching the rbk revision tibial peg or the rbk revision augment for added support. the device is intended to be fixed in place with bone cement. rbk revision tibia cemented is a cemented tibial baseplate component of the rbk system and is indicated for use in primary total knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with the following conditions: 1. non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, or avascular necrosis. 2. inflammatory degenerative joint disease including rheumatoid arthritis. 3. correction of functional deformity. 4. revision of primary uni-compartmental knee replacements.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 34198 - coated knee tibia prosthesis - the rbk tibia porous coated & ha is the tibial part of the rbk knee system used in total knee replacement surgery. the tibial component is made of cobalt-chrome-molybdenum alloy. the component is compatible with both the universal and highflex tibial inserts. the underside features four pegs and central cone for fixation, with a hydroxyapatite (ha) and porous coating to promote bone ingrowth. rbk tibia porous coated & ha is a cementless tibial baseplate component of the rbk system and is indicated for use in primary total knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with the following conditions: 1. non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, or avascular necrosis. 2. inflammatory degenerative joint disease including rheumatoid arthritis. 3. correction of functional deformity. 4. revision of primary uni-compartmental knee replacements.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

rbk nutraceuticals pty ltd - royal jelly lyophilised -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

rbk nutraceuticals pty ltd - shark cartilage, quantity: 750 mg - capsule, hard - excipient ingredients: gelatin; magnesium stearate; purified water - maintain/support general health and wellbeing ; maintain/support joint health

Australia - inglese - Department of Health (Therapeutic Goods Administration)

rbk nutraceuticals pty ltd - olea europaea,propolis -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

rbk nutraceuticals pty ltd - ascorbic acid,sodium ascorbate -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

rbk nutraceuticals pty ltd - olea europaea,propolis -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

rbk nutraceuticals pty ltd - shark cartilage, quantity: 160 mg; glucosamine hydrochloride, quantity: 620.5 mg (equivalent: glucosamine, qty 515 mg); green lipped mussel dried, quantity: 160 mg - tablet, film coated - excipient ingredients: hypromellose; microcrystalline cellulose; carnauba wax; povidone; titanium dioxide; macrogol 400; hydrogenated vegetable oil; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; crospovidone; croscarmellose sodium; magnesium stearate - maintain/support general health and wellbeing ; anti-inflammatory/relieve inflammation ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; maintain/support joint health ; decrease/reduce/relieve mild joint inflammation/swelling ; maintain/support joint mobility/flexibility

Australia - inglese - Department of Health (Therapeutic Goods Administration)

rbk nutraceuticals pty ltd - propolis, quantity: 400 mg/ml (equivalent: lead, qty 1 microgram/ml; equivalent: propolis resin, qty 80 mg/ml); olea europaea, quantity: 5 mg/ml (equivalent: olea europaea, qty 50 mg/ml) - spray - excipient ingredients: stevia rebaudiana; anethole; lemon oil; ethanol; peppermint oil; propylene glycol; honey; flavour - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; decrease/reduce/relieve symptoms of common colds and flu

Australia - inglese - Department of Health (Therapeutic Goods Administration)

rbk nutraceuticals pty ltd - royal jelly, quantity: 500 mg (equivalent: 10-hydroxy-2-decenoic acid, qty 30 mg) - capsule, hard - excipient ingredients: magnesium stearate; colloidal anhydrous silica; hypromellose; purified water - royal jelly is produced by worker bees to stimulate the growth and development of the queen bee. the queen bee lives 45 times longer than average worker bees. royal jelly is a natural source of the special active substances like 10-hda. 10-hda is will known for its revitalizing and immune supporting ability. mothernest royal jelly powder is a rich source of various vitamins and 10-hda which may help to boost your immune system and energize your body.